Immuron (IMRN) EBITDA (2016 - 2024)
Immuron has reported EBITDA over the past 9 years, most recently at $1660259127.7 billion for Q4 2024.
- For Q4 2024, EBITDA rose 1.2625362290076214e+16% year-over-year to $1660259127.7 billion; the TTM value through Dec 2024 reached $1660259114.5 billion, up 12517374508.53%, while the annual FY2025 figure was -$3.4 million, 9.08% up from the prior year.
- EBITDA for Q4 2024 was $1660259127.7 billion at Immuron, up from -$13150.2 in the prior quarter.
- Over five years, EBITDA peaked at $1660259127.7 billion in Q4 2024 and troughed at -$13.3 billion in Q4 2021.
- A 5-year average of $237179873.5 billion and a median of -$13150.2 in 2023 define the central range for EBITDA.
- Biggest five-year swings in EBITDA: plummeted 23116432.23% in 2021 and later surged 1.2625362290076214e+16% in 2024.
- Year by year, EBITDA stood at -$57371.6 in 2020, then plummeted by 23116432.23% to -$13.3 billion in 2021, then skyrocketed by 100.01% to $1.8 million in 2022, then plummeted by 100.72% to -$13150.2 in 2023, then soared by 1.2625362290076212e+16% to $1660259127.7 billion in 2024.
- Business Quant data shows EBITDA for IMRN at $1660259127.7 billion in Q4 2024, -$13150.2 in Q4 2023, and $2.4 million in Q3 2023.